SCHEMBL8980163

SCHEMBL8980163

C[C@]12CCC(=O)C=C1C(=O)C[C@@H]1[C@@H]2CC[C@]2(C)C(=O)NC[C@@H]12

nearest known ligand 0.68

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP19A1 P11511 14/20 0.68
SMN1; SMN2 Q16637 6/20 0.44
ALDH1A1 P00352 4/20 0.44
MAPK1 P28482 3/20 0.44
BLM P54132 3/20 0.44
PMP22 Q01453 3/20 0.44
NPSR1 Q6W5P4 3/20 0.44
HSD17B10 Q99714 3/20 0.44
NR1I2 O75469 2/20 0.44
NR3C1 P04150 2/20 0.44
PGR P06401 2/20 0.44
NR3C2 P08235 2/20 0.44
CYP3A4 P08684 2/20 0.44
AR P10275 2/20 0.44
NR1H4 Q96RI1 2/20 0.44
MAPT P10636 2/20 0.44
TSHR P16473 2/20 0.44
ESR1 P03372 1/20 0.44
TP53 P04637 1/20 0.44
VDR P11473 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8980169 1.00 CYP19A1 (0.68) CYP19A1SMN1; SMN2ALDH1A1MAPK1BLM
SCHEMBL42713 0.81 CYP19A1 (1.00) CYP19A1SMN1; SMN2ALDH1A1MAPK1BLM
SCHEMBL42712 0.81 CYP19A1 (1.00) CYP19A1SMN1; SMN2ALDH1A1MAPK1BLM
SCHEMBL2600419 0.81 CYP19A1 (1.00) CYP19A1SMN1; SMN2ALDH1A1MAPK1BLM
SCHEMBL1900489 0.81 CYP19A1 (0.70) CYP19A1SMN1; SMN2ALDH1A1MAPK1BLM
SCHEMBL1900487 0.81 CYP19A1 (0.70) CYP19A1SMN1; SMN2ALDH1A1MAPK1BLM
SCHEMBL8760343 0.81 SHBG (0.67) CYP19A1SMN1; SMN2ALDH1A1MAPK1BLM
SCHEMBL8760349 0.81 SHBG (0.67) CYP19A1SMN1; SMN2ALDH1A1MAPK1BLM
SCHEMBL6821320 0.80 CYP19A1 (0.78) CYP19A1SMN1; SMN2ALDH1A1MAPK1BLM
SCHEMBL7097095 0.80 CYP19A1 (0.78) CYP19A1SMN1; SMN2ALDH1A1MAPK1BLM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5519051-A AROMATASE INHIBITORS USEFUL FOR TREATMENT OF DISEASES CAUSED BY EXCESS OF ESTROGEN, FOR EXAMPLE, BREAST CANCER, UTERINE CANCER TEIKOKU HORMONE MFG. CO., LTD. (JP) 1996-05-21 US disclosed
EP-0582713-A1 NOVEL OXA- OR AZASTEROID DERIVATIVE TEIKOKU HORMONE MFG. CO., LTD. (JP) 1994-02-16 EP disclosed